EVALUATION OF CLINICAL AND ECONOMIC OUTCOMES ASSOCIATED WITH POTENTIAL MISCLASSIFICATION OF CLOSTRIDIUM DIFFICILE INFECTION
Author(s)
Keum J1, Vu M1, Jacob B1, Peasah S1, Shogbon A1, Watkins JL2, Bressler A2
1Mercer University College of Pharmacy, Atlanta, GA, USA, 2DeKalb Medical Center, Decatur, GA, USA
OBJECTIVES: The Centers for Medicare and Medicaid Services (CMS) require public reporting of Clostridium difficile infection (CDI) rates as part of the Inpatient Quality Reporting Program. Under-performing hospitals may be at risk for significant financial penalties. This study evaluated incremental health care resource use and costs associated with potential misclassification of CDI. METHODS: This was a retrospective, observational study of inpatient adults with a positive stool sample for Clostridium difficile from January 1, 2015 to March 31, 2016 at a community hospital. Patients were classified as definite community-onset CDI (positive stool sample within 3 days of admission) or healthcare facility-onset (positive stool sample at least 3 days post-admission). The healthcare facility-onset group was analyzed to identify symptomatic patients within 3 days of admission but had a ≥3 day delay in sampling stool for Clostridium difficile
Conference/Value in Health Info
2017-05, ISPOR 2017, Boston, MA, USA
Value in Health, Vol. 20, No. 5 (May 2017)
Code
PIN70
Topic
Economic Evaluation, Health Policy & Regulatory
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Reimbursement & Access Policy
Disease
Infectious Disease (non-vaccine)
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now